Press release
Cosmetic CDMO Market to Reach USD 35.79 Billion by 2033 | CAGR 5.4% | Driving Innovation, Sustainability & Personalized Skincare Solutions
The global cosmetic CDMO market reached US$ 22.44 billion in 2023, rising to US$ 23.50 billion in 2024, and is projected to reach US$ 35.79 billion by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033. The market growth is driven by the increasing demand for innovation, sustainability, and customization in the beauty industry, positioning contract development and manufacturing organizations (CDMOs) as key enablers of modern cosmetic solutions. CDMOs provide advanced formulation expertise, scalable manufacturing, and eco-conscious packaging, allowing brands to deliver safer, more effective, and consumer-driven products. Rising trends such as clean-label beauty, natural and dermatology-backed ingredients, and environmentally sustainable formulations align with evolving consumer expectations for product performance and sustainability. Additionally, the growth of indie and private-label brands is creating new opportunities for agile, full-service CDMO partnerships, further driving market expansion.Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/cosmetic-cdmo-market?Juli
Recent Developments:
✅ March 2025: Lonza announced a strategic partnership with a leading global beauty brand to co-develop and manufacture clean-label cosmetic actives, expanding its contract development and manufacturing footprint for prestige skincare.
✅ June 2025: BASF secured a major contract with a multinational consumer goods company to supply sustainably sourced cosmetic ingredients via its CDMO-enabled supply chain, reinforcing its role in eco-conscious cosmetic formulation.
✅ April 2025: Croda International launched a new bio-based emulsifier platform for cosmetic applications, enabling faster formulation development for improved scent, color, and moisture retention across multiple product lines.
✅ August 2025: 1Q Health Group, backed by European private equity, acquired Beauty Production GmbH, a specialist in liquid dietary supplements and cosmetics, thereby strengthening its end-to-end cosmetic CDMO capabilities in Germany and Austria.
✅ Ongoing 2024-2025: CDMO partners are increasingly serving as innovation partners in the beauty industry, supporting personalized skincare and niche product development to accelerate market responsiveness and brand differentiation.
Mergers & Acquisitions:
✅ July 2025: Catalent, Inc. acquired a European-based specialty cosmetic CDMO, expanding its end-to-end formulation, manufacturing, and packaging capabilities for skincare and personal care brands.
✅ May 2025: Fareva Group completed the acquisition of a U.S. niche cosmetic manufacturer, strengthening its position in clean-label and natural cosmetic CDMO services.
✅ February 2025: Olivo Laboratories merged with a private-label skincare CDMO to enhance its R&D and high-volume manufacturing capabilities for anti-aging and dermatology-backed cosmetic products.
✅ October 2024: Cosmetic Solutions, Inc. acquired a smaller specialty cosmetic formulation firm, enabling faster turnaround for indie brands and enhancing its private-label service offerings.
✅ Ongoing 2024-2025: The cosmetic CDMO sector is witnessing strategic consolidation, with larger players acquiring niche, innovative CDMOs to broaden their service portfolio, improve geographic coverage, and accelerate time-to-market for clients.
Key Players:
Fareva Group | INTERCOS | Catalent, Inc. | TOYO BEAUTY | Swiss American
Key Highlights:
• Fareva Group - Holds a 20% market share, driven by its full-service CDMO capabilities spanning skincare, haircare, and color cosmetics, with strong expertise in sustainable and clean-label formulations.
• INTERCOS - Holds a 18% share, supported by its advanced formulation R&D, high-volume manufacturing, and color cosmetics specialization for global beauty brands.
• Catalent, Inc. - Holds a 16% share, fueled by its end-to-end contract development and manufacturing solutions, including scalable production and packaging services for prestige and mass-market cosmetics.
• TOYO BEAUTY - Holds a 14% share, driven by innovative private-label solutions, rapid product development, and strong focus on Asian cosmetic markets.
• Swiss American - Holds a 12% share, supported by its niche offerings in dermatology-backed cosmetic formulations, including natural and bioactive ingredient-based products.
• Others - Account for 20% share, including small to mid-sized regional CDMOs providing specialized services for indie brands, private-label manufacturers, and niche cosmetic segments.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cosmetic-cdmo-market?Juli
Market Segmentation:
➥By Service Type, Product Development dominates with a 35% share, driven by increasing demand for innovative formulations, natural and clean-label solutions, and rapid R&D capabilities that help brands differentiate their products. Product Manufacturing holds a 30% share, supported by scalable production facilities, flexible batch sizes, and expertise across skincare, haircare, and personal care segments. Quality Control & Regulatory Support contributes 20%, offering safety testing, compliance monitoring, and adherence to global cosmetic regulations. Packaging & Labeling accounts for 15%, fueled by demand for sustainable, visually appealing, and customized packaging solutions that enhance brand recognition.
➥By Product Type, Skincare Products lead with a 40% share, due to high consumer demand for anti-aging, hydration, and sun-care solutions. Haircare Products account for 25%, driven by innovative shampoos, conditioners, and treatment formulations. Fragrances & Deodorants contribute 20%, supported by growing preferences for personalized scents and wellness-oriented products. Other Personal Care Products make up 15%, including niche offerings such as bath, body, and oral care products.
➥By End-User, Multinational Cosmetic Companies hold a 55% share, leveraging CDMOs for large-scale manufacturing, formulation innovation, and global regulatory compliance. Independent & Emerging Beauty Brands account for 45%, relying on agile CDMO partners for rapid product development, private-label manufacturing, and customized services to compete in niche markets.
Regional Insights:
North America dominates the Cosmetic CDMO Market with a 35% share, driven by the presence of major multinational cosmetic brands, strong demand for clean-label and dermatology-backed products, and advanced contract manufacturing infrastructure. The U.S. leads the region due to high R&D investments, adoption of sustainable packaging, and growing indie and private-label beauty brands.
Europe holds a 30% share, supported by stringent regulatory frameworks, sustainability-focused initiatives, and a strong presence of specialty CDMOs offering high-quality skincare, color cosmetics, and haircare solutions. Countries such as France, Germany, and Italy are investing heavily in innovation, natural ingredient formulations, and eco-friendly packaging, fueling market growth.
Asia-Pacific is the fastest-growing region, accounting for 25% of the market, with a projected CAGR of over 7% during 2025-2033. Rapid urbanization, rising disposable incomes, increasing beauty consciousness, and demand for skincare and personal care products in countries like China, India, South Korea, and Japan are driving CDMO services. Emerging local brands are increasingly partnering with CDMOs for agile product development and private-label manufacturing.
Latin America, Middle East & Africa (LAMEA) collectively contribute 10% of the market. Growth is supported by rising beauty awareness, expansion of multinational cosmetic companies, and increasing investments in contract manufacturing capabilities. Key markets include Brazil, Mexico, South Africa, and the UAE, where CDMOs are enabling access to high-quality formulations and customized cosmetic solutions.
Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/cosmetic-cdmo-market?Juli
Market Dynamics:
Drivers:
Rising Demand for Personalized and Premium Skincare is a major growth driver for the cosmetic CDMO market. Consumers increasingly seek products tailored to their unique skin types, concerns, and lifestyles, pushing cosmetic brands to partner with CDMOs that offer advanced R&D and formulation capabilities. Premium skincare often requires specialized ingredients, cutting-edge technologies, and strict safety testing, which many brands find more efficient to outsource. CDMOs provide expertise in innovative formulations, enable scalability, and facilitate faster product launches, helping brands meet evolving consumer expectations without compromising quality. Strategic collaborations, acquisitions, and partnerships further strengthen CDMO capabilities. For instance, in August 2025, Germany-based CDMO 1Q Health Group, backed by Nord Holding, acquired Beauty Production GmbH, enhancing its end-to-end development and manufacturing capabilities in liquid dietary supplements and cosmetics. By serving as innovation partners, CDMOs are transforming personalized skincare into a mainstream market force, accelerating market growth.
Restraints:
High Regulatory and Compliance Requirements present a significant challenge for the Cosmetic CDMO market. Cosmetics are subject to stringent safety, labeling, and ingredient standards across regions, including the FDA in the U.S., EU Cosmetics Regulation in Europe, and similar authorities in Asia-Pacific. Compliance with diverse and evolving regulations requires CDMOs to invest heavily in testing facilities, documentation processes, and regulatory expertise, increasing operational costs and slowing product development cycles. This complexity can limit the entry of smaller players and pose challenges for scaling operations globally.
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cosmetic CDMO Market to Reach USD 35.79 Billion by 2033 | CAGR 5.4% | Driving Innovation, Sustainability & Personalized Skincare Solutions here
News-ID: 4326505 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Telestroke Services Market to Reach USD 5.16 Billion by 2033 | CAG …
Telestroke Services Market Size & Industry Outlook
The global Telestroke Services Market reached US$ 1.87 billion in 2024, rising from US$ 1.68 billion in 2023, and is projected to reach US$ 5.16 billion by 2033, growing at a strong CAGR of 12.1% during the forecast period 2025-2033. The market's rapid expansion is driven by the increasing demand for timely stroke care and remote neurological consultation, particularly in underserved and rural regions…
United States Interoperable Healthcare Information Technology (Health IT) System …
Market Size and Growth
Global Interoperable Healthcare Information Technology (Health IT) Systems Market reached US$ 3.08 billion in 2024 and is expected to reach US$ 23.18 billion by 2033, growing at a CAGR of 22.3% during the forecast period 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/interoperable-healthcare-information-technology-systems-market?sb
Key Development:
United States: Recent Industry Developments
✅ In November 2025, NTT DATA Healthcare launched a cross-institutional interoperability service…
Interventional Radiology Market to Expand at a 5% CAGR During 2024-2031 | Driven …
According to DataM Intelligence, the global interventional radiology market is expected to grow at a CAGR of 5% during the forecast period 2024-2031. Market growth is supported by the increasing preference for minimally invasive procedures, rising prevalence of chronic diseases, and continuous advancements in imaging technologies. Interventional radiology offers reduced recovery time, lower procedural risk, and improved clinical outcomes compared to conventional surgical approaches, making it increasingly adopted across healthcare…
United States Attention Deficit Hyperactivity Disorder (ADHD) Market 2033 | Grow …
Market Size and Growth
Attention Deficit Hyperactivity Disorder (ADHD) Market size reached US$ 16.23 billion in 2024 and is expected to reach US$ 27.04 billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/attention-deficit-hyperactivity-disorder-adhd-market?sb
Key Development:
United States: Recent ADHD Developments
✅ In November 2025, Otsuka Pharmaceutical submitted a New Drug Application to the…
More Releases for CDMO
FDP CDMO Research: China FDP CDMO market size is projected to reach USD 1.33 bil …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Fraud Detection and Prevention (FDP) System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the…
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
